Multi-faced neuroprotective effects of geniposide depending on the RAGE-mediated signaling in an Alzheimer mouse model
- 1 February 2015
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 89, 175-184
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81274118, 81230010)
- Key New Drug Creation and Development Program of China (2012ZX09103-201)
This publication has 58 references indexed in Scilit:
- A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer diseaseJournal of Clinical Investigation, 2012
- The contribution of activated astrocytes to Aβ production: Implications for Alzheimer's disease pathogenesisJournal of Neuroinflammation, 2011
- The 1.5 Å Crystal Structure of Human Receptor for Advanced Glycation Endproducts (RAGE) Ectodomains Reveals Unique Features Determining Ligand BindingJournal of Biological Chemistry, 2010
- The RAGE AxisCirculation Research, 2010
- RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's diseaseThe FASEB Journal, 2009
- Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behaviorBehavioural Brain Research, 2008
- AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine LossNeuron, 2006
- Morris water maze: procedures for assessing spatial and related forms of learning and memoryNature Protocols, 2006
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brainNature Medicine, 2003
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996